Big Pharma loses in three court battles over Medicare drug price negotiations


The following is from Public Citizen.


Three federal courts have rejected challenges to the Medicare drug price negotiation in separate cases over the last two days, marking a win for consumers and a blow to Big Pharma and the US Chamber of Commerce.

The US Court of Appeals for the Second Circuit today denied Boehringer Ingelheim’s bid to block Medicare from negotiating lower drug prices. In another decision today, a federal district court in Texas dismissed the Pharmaceutical Research and Manufacturers of America’s (PHRMA) claim that the program was unconstitutional. Yesterday, the US Court of Appeals for the Sixth Circuit refused the US Chamber of Commerce’s constitutional challenge to the program.

Public Citizen, along with Doctors for America, Protect Our Care, and Families USA, filed amicus briefs supporting the government and defending the program’s constitutionality. In March, Public Citizen issued an issue brief stating that while Medicare drug price negotiation is a step forward in regulating drug prices, loopholes and restrictions in the law already limit savings for patients and taxpayers.

“The drug industry is faltering in its attempts to use the Constitution and the courts to avoid negotiating fair prices with Medicare,” said Public Citizen Attorney Nandan Joshi. “From New York to Texas, courts are rejecting the industry’s efforts to profit off of Medicare while charging seniors sky-high prices for brand name drugs.”

Read the full press release here.

Follow The Science by Sharyl Attkisson

Leave a Comment

Your email address will not be published. Required fields are marked *

4 thoughts on “Big Pharma loses in three court battles over Medicare drug price negotiations”

  1. Creon, a digestive enzymes needed for life in most cases to treat EPI (Exocrine Pancreas Insufficiency).
    Out of pocket w/out insurance – USA 30-day supply ranges between $3600-$4200
    Out of pocket w/out insurance – Italy 30 day supply — about 30 euros (about $40)

    There is no generic for this or Zenpep, the only two prescription digestive enzymes to treat this serious condition. If untreated, the cost to Medicare will be far greater when the patient has to be hospitalized. It’s insane.

    Where in God’s name is the logic in that except to milk

  2. Earline D. Lizarraga

    Google pays $300 on a regular basis. My latest salary check was $8600 for working 10 hours a week on the internet. My younger sibling has been averaging $19k for the last few months, and he constantly works approximately 24 hours. I’m not sure how simple it was once I checked it out.

    This is my main concern………. https://bigpro223.blogspot.com/

  3. Google pays $300 on a regular basis. My latest salary check was $8600 for working 10 hours a week on the internet. My younger sibling has been averaging $19k for the last few months, and he constantly works approximately 24 hours. I’m not sure how simple it was once I checked it out.

    This is my main concern……….

Scroll to Top